Videos

Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.

Claire Friedman discusses the factors clinicians should consider when determining an immunotherapy treatment plan for older patients.

Supriya Mohile discusses the disparity that can exist between patients in clinical trials and patients that providers experience in the real world.

Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.

Elizabeth Repasky, PhD, discusses the effect that lifestyle factors can have on immune reponses in patients with cancer.

Sam Smith, PhD, discusses the relationship between menopausal symptoms and non-adherence in patients receiving tamoxifen.

Krista Qualmann discusses hereditary cancer syndromes.

Beth Sandy discusses the use of anti-psychotoci agent, olanzapine, when managing chemotherapy-induced nausea and vomiting (CINV).

Jeannine Brant discusses factors that can influence a patient's perception of malignant pain.

Laura Wood on collaboration between departments when treating patients with cancer who are receiving immunotherapy treatments.

Debu Tripathy discuss how to encouragecompliance and adherence for patients with breast cancer who are receiving hormone therapy.

Karen Lee explains why it is important for patients to understand immunotherapy and how nurses can help them in patients education.

Jame Abraham highlights the importance of time management for patients undergoing scalp cooling.

Krista Qualmann explains what a meeting with a genetic counselor will look like for a patient.

Molly Freeman explains why it is necessary for providers to be educated on stereotactic body radiation therapy.

Jennifer Klemp, PhD, MPH, discusses the importance of measuring outcomes in survivorship care for patients with cancer.

Melissa Andres explains the role of the nurse navigator for patients with cancer.

Mikel Ross discusses the different costs of cooling cap interventions for chemotherapy-induced hair loss and insurance coverage.

Beth Sandy points out what nurses should keep in mind when managing a patient with cancer's chemotherapy-induced nausea and vomiting.

Julie Nangia explains the process for the Orbis Paxman Hair Loss Prevention System.

Jeannine Brant discusses the effect of recent focus on opioid and opioid addiction on the use of opioid agents in pain management of patients with cancer.

Ann Culkin, MD, discusses how to ease patient fears of cancer treatment-related side effects.

Karen Lee discusses the the importance of an actively involved caregiver for patients with cancer.

Debu Tripathy on the management of patients with breast cancer on oral oncolytics.

Sam Smith, PhD, from the University of Leeds, discusses strategies to improve adherence that is affected by menopausal symptoms.

Jame Abraham on the patient experience during scalp cooling for chemotherapy-induced hair loss.

Julie Nangia, MD, gives advice for patients expecting to lose their hair as a result of chemotherapy.